Jeffrey D Serrill Selected Research

apoptolidin A

2/2015

Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey D Serrill Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 01/2013
2	Glioblastoma (Glioblastoma Multiforme) 02/2016 - 01/2013
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Pancreatitis 01/2018
1	Metaplasia 01/2018
1	Weight Gain 01/2018
1	Breast Neoplasms (Breast Cancer) 02/2016
1	Weight Loss (Weight Reduction) 02/2016

Drug/Important Bio-Agent (IBA)

5	coibamide AIBA 01/2021 - 01/2013
4	Biological ProductsIBA 01/2021 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	DepsipeptidesIBA 02/2016 - 03/2015
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	PlatinumIBA 01/2022
1	ProteomeIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	SEC Translocation ChannelsIBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	apratoxin AIBA 01/2020
1	ipomoeassin FIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	mandelalide AIBA 03/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2016
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2015
1	apoptolidin AIBA 02/2015
1	apoptolidinIBA 02/2015
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Cytotoxins (Cytolysins)IBA 01/2013
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2013